Biotoxtech Co., Ltd. (KOSDAQ:086040)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,445.00
+50.00 (2.09%)
At close: Jun 18, 2026
Market Cap34.82B -23.5%
Revenue (ttm)47.64B +9.3%
Net Income769.13M
EPS49.48
Shares Out 15.72M
PE Ratio44.77
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume20,870
Open2,400.00
Previous Close2,395.00
Day's Range2,380.00 - 2,450.00
52-Week Range2,265.00 - 4,115.00
Beta0.43
AnalystsBuy
Price Target15,000.00 (+513.5%)
Earnings DateAug 14, 2026

About Biotoxtech

Biotoxtech Co., Ltd. engages in the safety evaluation of synthetic medicines, biomedicines, cell therapy products, gene therapy products, health functional foods, chemicals, and pesticides in South Korea. It is involved in testing and substance screening, clinical pathology and histopathology work, and consulting and government affairs related to non-clinical trials, as well as new drug development. The company’s safety evaluation research field includes general toxicity test, carcinogenicity studies, local toxicity studies, reproductive and de... [Read more]

Industry Medical Laboratories
Founded 2000
Employees 188
Stock Exchange KOSDAQ
Ticker Symbol 086040
Full Company Profile

Financial Performance

Financial Statements